Ymab shareholder alert: jakubowitz law reminds y-mabs shareholders of a lead plaintiff deadline of march 20, 2023

New york , march 3, 2023 /prnewswire/ -- jakubowitz law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of y-mabs therapeutics, inc. (nasdaq: ymab). to receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/y-mabs-therapeutics-inc-loss-submission-form/?id=36966&from=4 this lawsuit is on behalf of persons or entities who purchased shares of y-mabs therapeutics, inc. common stock on the open market or pursuant to registration statements filed with the u.s. securities and exchange commission during the period october 6, 2020 through october 28, 2022, inclusive.
YMAB Ratings Summary
YMAB Quant Ranking